UNSPSC 51422512: Hydrocortamate hydrochloride

This classification denotes a therapeutic glucocorticoid with the molecular formula C27H41NO6.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 9QM8U7R83W, chemically known as 11beta,17alpha,21-trihydroxypregn-4-ene-3,20-dione 21-diethylaminoacetate hydrochloride but more generally known as hydrocortamate hydrochloride, which bears US NIH Compound Identifier 31312. Most nations, for tariff and trade purposes, schedule hydrocortamate hydrochloride under HS 29372900 and SITC 54153.

As of Q4 2014, HYDROCORTAMATE HYDROCHLORIDE remains US FDA's Preferred Term for this commodity. Hydrocortamate hydrochloride bears US NLM identifiers UMLS ID C1445700 and NCI Concept Code C65863. SMILES: CCN(CC)CC(=O)OCC(=O)[C@]1(CC[C@@H]2[C@@]1(C[C@@H]([C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C)O)C)O.CL.

UNSPSC 51422512 Hydrocortamate hydrochloride is a Commodity code that in current state and local procurement activity encompasses emergency-response pharmaceuticals and drug-deactivation systems rather than hydrocortamate specifically. Seminole County, Florida's recent IFB for naloxone and safe drug deactivation systems—posted June 30, 2026, with a response deadline of July 26, 2026—illustrates the scope of work actually being bought: counties are procuring naloxone kits and associated deactivation equipment to support community health and overdose-response initiatives. The issuing body mix remains limited in the available record; county health and emergency-services departments appear to be the primary purchasing entities. Vendors responding to opportunities under this code must meet standard state and local compliance requirements including drug-free workplace certification, E-Verify enrollment, and appropriate insurance (workers' compensation, commercial general liability, and professional liability).

The geographic activity visible in recent opportunities centers on Florida. Seminole County's IFB called for 1,900 units of naloxone and 800 safe drug deactivation systems annually, with quarterly deliveries to the Seminole County Community Health Building in Sanford. The contract structure includes an initial two-year term with a one-year renewal option and a three-month probationary period. Vendors must absorb shipping and delivery costs in their pricing and submit bids electronically through the county's e-Procurement Portal. The procurement does not specify set-aside designations for disadvantaged enterprises, though potential FEMA funding introduces compliance obligations under the Clean Air Act and Federal Water Pollution Control Act. State and local buying activity under this code remains sparse in recent records.